By being undiagnosed or untreated, a significant fraction of people with obesity or overweight are not getting the recommended care, despite an increase in new treatment options, according to research being presented on June 17 at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer’s Blood Test Assessed
Antibody response to anti-Epstein-Barr virus nuclear antigen 1 (EBNA-1) may be a risk factor for multiple sclerosis (MS), a small study suggested. (JAMA Neurology) ND0612,